|Articles|May 21, 2019
Navitas Life Sciences Announces Acquisition of KAI CRO
Advertisement
Navitas Life Sciences announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc. KAI Research brings offerings in three key areas to the table – Clinical Trial Management, Clinical Research Consultation, and Data Management & Standardization.
For more details on the acquisition, click
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
5